These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12624308)
21. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Bourdeau A; Cymerman U; Paquet ME; Meschino W; McKinnon WC; Guttmacher AE; Becker L; Letarte M Am J Pathol; 2000 Mar; 156(3):911-23. PubMed ID: 10702408 [TBL] [Abstract][Full Text] [Related]
22. Oxidative stress contributes to endothelial dysfunction in mouse models of hereditary hemorrhagic telangiectasia. Jerkic M; Sotov V; Letarte M Oxid Med Cell Longev; 2012; 2012():686972. PubMed ID: 23320130 [TBL] [Abstract][Full Text] [Related]
23. Endoglin has a crucial role in blood cell-mediated vascular repair. van Laake LW; van den Driesche S; Post S; Feijen A; Jansen MA; Driessens MH; Mager JJ; Snijder RJ; Westermann CJ; Doevendans PA; van Echteld CJ; ten Dijke P; Arthur HM; Goumans MJ; Lebrin F; Mummery CL Circulation; 2006 Nov; 114(21):2288-97. PubMed ID: 17088457 [TBL] [Abstract][Full Text] [Related]
24. Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality. Torsney E; Charlton R; Diamond AG; Burn J; Soames JV; Arthur HM Circulation; 2003 Apr; 107(12):1653-7. PubMed ID: 12668501 [TBL] [Abstract][Full Text] [Related]
25. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling. Tual-Chalot S; Garcia-Collado M; Redgrave RE; Singh E; Davison B; Park C; Lin H; Luli S; Jin Y; Wang Y; Lawrie A; Jakobsson L; Arthur HM Circ Res; 2020 Jan; 126(2):243-257. PubMed ID: 31805812 [TBL] [Abstract][Full Text] [Related]
26. Endoglin deficiency impairs stroke recovery. Shen F; Degos V; Chu PL; Han Z; Westbroek EM; Choi EJ; Marchuk D; Kim H; Lawton MT; Maze M; Young WL; Su H Stroke; 2014 Jul; 45(7):2101-6. PubMed ID: 24876084 [TBL] [Abstract][Full Text] [Related]
27. A murine model of hereditary hemorrhagic telangiectasia. Bourdeau A; Dumont DJ; Letarte M J Clin Invest; 1999 Nov; 104(10):1343-51. PubMed ID: 10562296 [TBL] [Abstract][Full Text] [Related]
28. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Seki T; Yun J; Oh SP Circ Res; 2003 Oct; 93(7):682-9. PubMed ID: 12970115 [TBL] [Abstract][Full Text] [Related]
29. Vascular defects associated with hereditary hemorrhagic telangiectasia revealed in patient-derived isogenic iPSCs in 3D vessels on chip. Orlova VV; Nahon DM; Cochrane A; Cao X; Freund C; van den Hil F; Westermann CJJ; Snijder RJ; Ploos van Amstel JK; Ten Dijke P; Lebrin F; Mager HJ; Mummery CL Stem Cell Reports; 2022 Jul; 17(7):1536-1545. PubMed ID: 35777360 [TBL] [Abstract][Full Text] [Related]
30. Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse. Choi EJ; Walker EJ; Shen F; Oh SP; Arthur HM; Young WL; Su H Cerebrovasc Dis; 2012; 33(6):540-7. PubMed ID: 22571958 [TBL] [Abstract][Full Text] [Related]
31. Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia. Sugden WW; Siekmann AF Curr Opin Hematol; 2018 May; 25(3):237-244. PubMed ID: 29438260 [TBL] [Abstract][Full Text] [Related]
32. Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations. Matsubara S; Bourdeau A; terBrugge KG; Wallace C; Letarte M Stroke; 2000 Nov; 31(11):2653-60. PubMed ID: 11062290 [TBL] [Abstract][Full Text] [Related]
33. Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia. Bourdeau A; Faughnan ME; Letarte M Trends Cardiovasc Med; 2000 Oct; 10(7):279-85. PubMed ID: 11343967 [TBL] [Abstract][Full Text] [Related]
34. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Arthur HM; Ure J; Smith AJ; Renforth G; Wilson DI; Torsney E; Charlton R; Parums DV; Jowett T; Marchuk DA; Burn J; Diamond AG Dev Biol; 2000 Jan; 217(1):42-53. PubMed ID: 10625534 [TBL] [Abstract][Full Text] [Related]
35. Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management. Stuhrmann M; El-Harith el-HA Saudi Med J; 2007 Jan; 28(1):11-21. PubMed ID: 17206283 [TBL] [Abstract][Full Text] [Related]
36. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Cymerman U; Vera S; Pece-Barbara N; Bourdeau A; White RI; Dunn J; Letarte M Pediatr Res; 2000 Jan; 47(1):24-35. PubMed ID: 10625079 [TBL] [Abstract][Full Text] [Related]
37. Characterization of 17 novel endoglin mutations associated with hereditary hemorrhagic telangiectasia. Cymerman U; Vera S; Karabegovic A; Abdalla S; Letarte M Hum Mutat; 2003 May; 21(5):482-92. PubMed ID: 12673790 [TBL] [Abstract][Full Text] [Related]
38. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling. Jin Y; Muhl L; Burmakin M; Wang Y; Duchez AC; Betsholtz C; Arthur HM; Jakobsson L Nat Cell Biol; 2017 Jun; 19(6):639-652. PubMed ID: 28530660 [TBL] [Abstract][Full Text] [Related]
39. Arterial endoglin does not protect against arteriovenous malformations. Singh E; Redgrave RE; Phillips HM; Arthur HM Angiogenesis; 2020 Nov; 23(4):559-566. PubMed ID: 32506200 [TBL] [Abstract][Full Text] [Related]
40. Increasing Endoglin Deletion in Endothelial Cells Exacerbates the Severity of Brain Arteriovenous Malformation in Mouse. Shabani Z; Do Prado LB; Zhang R; Zhu W; Shaligram SS; Yadav A; Wang C; Su H Biomedicines; 2024 Jul; 12(8):. PubMed ID: 39200156 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]